In Re: Mirena IUS Levonorgestrel-Related Products Liability Litigation

Docket Number19-2155
Decision Date08 December 2020
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
49 cases
  • In re Incretin-Based Therapies Prods. Liab. Litig.
    • United States
    • U.S. District Court — Southern District of California
    • March 9, 2021
    ...F. Supp. 2d at 1172 (citing In re Hanford Nuclear Reservation Litig. , 292 F.3d at 1133 ); In re Mirena IUS Levonorgestrel-Related Prod. Liab. Litig. (No. II) , 982 F.3d 113, 124 (2d Cir. 2020) (approving of the district court's "holding that there is a general causation requirement across ......
  • Capri Sun GmbH v. American Beverage Corporation
    • United States
    • U.S. District Court — Southern District of New York
    • March 31, 2022
    ...the jury." In re Mirena IUS Levonorgestrel-Related Prod. Liab. Litig. (No. II) , 341 F. Supp. 3d 213, 240 (S.D.N.Y. 2018), aff'd , 982 F.3d 113 (2d Cir. 2020). "[T]he proponent of expert testimony has the burden of establishing by a preponderance of the evidence that the admissibility requi......
  • Watson v. Manhattan Luxury Automobiles, Inc.
    • United States
    • U.S. District Court — Southern District of New York
    • September 29, 2022
    ... ... No. 20 Civ. 4572 (LGS) United States District Court, ... hand.'” In re Mirena IUS Levonorgestrel-Related ... Prods. Liab. Litig. (No. II) , 982 F.3d 113, 122-23 (2d ... ...
  • United States v. Smith
    • United States
    • U.S. Court of Appeals — Second Circuit
    • December 8, 2020
    ... ... Damon, Defendant-Appellant.Docket No. 19-3139August Term, 2020United States Court of ... ...
  • Request a trial to view additional results
2 firm's commentaries
  • Another Weird Alabama Decision
    • United States
    • LexBlog United States
    • March 18, 2024
    ...2018), and In re Mirena IUS Levonorgestrel-Related Products Liability Litigation (No. II), 387 F. Supp.3d 323, 341 (S.D.N.Y. 2019), aff’d, 982 F.3d 113 (2d Cir. 2020)) (other citations, quotation marks, and footnotes omitted). Indeed, shortly after the above-quoted Mirena decision, we compi......
  • Zantac MDL Decision Reinforces Principle That Lack Of General Acceptance Of An Expert's Conclusions Raises A Red Flag
    • United States
    • Mondaq United States
    • February 16, 2023
    ...court may fairly suspect that the principles and methods have not been faithfully applied.' See also Coning v. Bayer Pharma AG et al., 982 F. 3d 113, 124 (2d Cir 2020) ('the court was well within its discretion to consider whether plaintiffs' experts' conclusions were generally accepted by ......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT